PENMIX

PENMIX is a company operating in the pharmaceutical industry.

PENMIX maximizes the business efficiency by conducting the whole process of research planning, development, licensing, manufacturing, and so on. As we are an organization specialized in General Injectable and Penicillin, we have our own R&D and RA specialists for whole CDMO project management. General Injectable plant is newly constructed in 2013 complied with KGMP and JGMP. Also EUGMP inspection is proceeded in August 2022, and received EUGMP on December 2022. This year, we are planning to prepare for cGMP this year to aim exporting USA on 2026.

Company type

Products and services

Pharmaceutical Products / ATC coding, Custom Manufacturing, Finished Dosage Forms, Contract Services – Analytical & Lab Services

Markets

Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)

Address

PENMIX, Ohsong Blgd, 14 Jeongdong-gil,, Jung-gu, Seoul, Korea, Republic of, 100-120